Search Results - "Awada, Gil"

Assessment of Retinal Pigment Epithelium Alterations and Chorioretinal Vascular Network Analyses in Patients under Treatment with BRAF/MEK Inhibitor for Different Malignancies: A Pilot Study.

Authors: Fasolino, Giuseppe Awada, Gil Moschetta, Laura et al.

Source: Journal of Clinical Medicine. Feb2023, Vol. 12 Issue 3, p1214. 12p.

Phase II Clinical Trial of Trametinib and Low-Dose Dabrafenib in Advanced, Previously Treated BRAF V600 /NRAS Q61 Wild-Type Melanoma (TraMel-WT).

Authors: Awada, Gil Dirven, Iris Schwarze, Julia Katharina et al.

Source: JCO Precision Oncology. 12/1/2024, Vol. 8, p1-16. 16p.

Early Reassessment of Total Metabolic Tumor Volume on FDG-PET/CT in Advanced Melanoma Patients Treated with Pembrolizumab Predicts Long-Term Outcome.

Authors: Vermeulen, Sim Awada, Gil Keyaerts, Marleen et al.

Source: Current Oncology. Jun2021, Vol. 28 Issue 3, p1630-1640. 11p.

Choriocapillaris Assessment In Patients Under Mek-Inhibitor Therapy For Cutaneous Melanoma: An Optical Coherence Tomography Angiography Study.

Authors: Fasolino, Giuseppe Awada, Gil Koulalis, Jorgos Socrates et al.

Source: Seminars in Ophthalmology. 2021, Vol. 36 Issue 8, p765-771. 7p.

Prognostic Value of O -(2-¹⁸F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma.

Authors: Geens, Wietse Buyck, Félix Raes, Laurens et al.

Source: Journal of Nuclear Medicine. Jun2026, Vol. 67 Issue 6, p857-863. 7p.

A Phase 2 Clinical Trial of Trametinib and Low-Dose Dabrafenib in Patients with Advanced Pretreated NRAS Q61R/K/L Mutant Melanoma (TraMel-WT).

Authors: Awada, Gil Schwarze, Julia Katharina Tijtgat, Jens et al.

Source: Cancers. May2021, Vol. 13 Issue 9, p2010-2010. 1p.

A Comprehensive Analysis of Baseline Clinical Characteristics and Biomarkers Associated with Outcome in Advanced Melanoma Patients Treated with Pembrolizumab.

Authors: Awada, Gil Jansen, Yanina Schwarze, Julia Katharina et al.

Source: Cancers. Jan2021, Vol. 13 Issue 2, p168-168. 1p.

Learning from the “tsunami” of immune checkpoint inhibitors in 2015.

Authors: Kourie, Hampig Raphael Awada, Gil Awada, Ahmad Hussein

Source: Critical Reviews in Oncology/Hematology. May2016, Vol. 101, p213-220. 8p.

Detection of cell‐free tumor DNA in cerebrospinal fluid as a diagnostic biomarker for leptomeningeal melanoma metastasis: A case series.

Authors: Dirven, Iris Vounckx, Manon Kessels, Jolien I. et al.

Source: Pigment Cell & Melanoma Research. Nov2024, Vol. 37 Issue 6, p822-830. 9p.

Immune checkpoint inhibitor therapy for ACTH-secreting pituitary carcinoma: a new emerging treatment?

Authors: Sol, Bastiaan de Filette, Jeroen M. K. Awada, Gil et al.

Source: European Journal of Endocrinology. 2021, Vol. 184 Issue 1, pK1-K5. 5p.

Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.

Authors: Rogiers, Anne Leys, Christophe Lauwyck, Justine et al.

Source: Journal of Immunology Research. 7/21/2020, p1-11. 11p. 5 Charts, 2 Graphs.

Whole-Body MRI for the Detection of Recurrence in Melanoma Patients at High Risk of Relapse.

Authors: Jansen, Yanina J. L. Willekens, Inneke Seremet, Teofila et al.

Source: Cancers. Feb2021, Vol. 13 Issue 3, p442. 1p.

Undetectable circulating tumor DNA (ctDNA) levels correlate with favorable outcome in metastatic melanoma patients treated with anti-PD1 therapy.

Authors: Seremet, Teofila Jansen, Yanina Planken, Simon et al.

Source: Journal of Translational Medicine. 9/5/2019, Vol. 17 Issue 1, pN.PAG-N.PAG. 1p.

Prognostic Value of O-(2-¹⁸F-Fluoroethyl)-l-Tyrosine PET for Patients with Recurrent Glioblastoma.

Authors: Geens W Buyck F Raes L et al.

Source: Journal of nuclear medicine : official publication, Society of Nuclear Medicine [J Nucl Med] 2026 Jun 01; Vol. 67 (6), pp. 857-863. Date of Electronic Publication: 2026 Jun 01.

Publication Type: Journal Article

Journal Info: Publisher: Society of Nuclear Medicine Country of Publication: United States NLM ID: 0217410 Publication Model: Electronic Cited Medium: Internet ISSN: 1535-5667 (Electronic) Linking ISSN: 01615505 NLM ISO Abbreviation: J Nucl Med Subsets: MEDLINE

Successful treatment of MAP2K1 mutant stage IV-M1d melanoma with trametinib plus low-dose dabrafenib: a case report.

Authors: Dirven I Calliauw E Awada G et al.

Source: Frontiers in medicine [Front Med (Lausanne)] 2024 Sep 09; Vol. 11, pp. 1436774. Date of Electronic Publication: 2024 Sep 09 (Print Publication: 2024).

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: Frontiers Media S.A Country of Publication: Switzerland NLM ID: 101648047 Publication Model: eCollection Cited Medium: Print ISSN: 2296-858X (Print) Linking ISSN: 2296858X NLM ISO Abbreviation: Front Med (Lausanne) Subsets: PubMed not MEDLINE

The rapidly evolving paradigm of neoadjuvant immunotherapy across cancer types.

Authors: Awada G Cascone T van der Heijden MS et al.

Source: Nature cancer [Nat Cancer] 2025 Jun; Vol. 6 (6), pp. 967-987. Date of Electronic Publication: 2025 Jun 24.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE

Acute exudative polymorphous vitelliform maculopathy during pembrolizumab treatment for metastatic melanoma: a case report.

Authors: Lambert I Fasolino G Awada G et al.

Source: BMC ophthalmology [BMC Ophthalmol] 2021 Jun 05; Vol. 21 (1), pp. 250. Date of Electronic Publication: 2021 Jun 05.

Publication Type: Case Reports; Journal Article

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415 (Electronic) Linking ISSN: 14712415 NLM ISO Abbreviation: BMC Ophthalmol Subsets: MEDLINE

Intratumoral Combinatorial Administration of CD1c (BDCA-1)⁺ Myeloid Dendritic Cells Plus Ipilimumab and Avelumab in Combination with Intravenous Low-Dose Nivolumab in Patients with Advanced Solid Tumors: A Phase IB Clinical Trial.

Authors: Schwarze JK Awada G Cras L et al.

Source: Vaccines [Vaccines (Basel)] 2020 Nov 10; Vol. 8 (4). Date of Electronic Publication: 2020 Nov 10.

Publication Type: Journal Article

Journal Info: Publisher: MDPI AG Country of Publication: Switzerland NLM ID: 101629355 Publication Model: Electronic Cited Medium: Print ISSN: 2076-393X (Print) Linking ISSN: 2076393X NLM ISO Abbreviation: Vaccines (Basel) Subsets: PubMed not MEDLINE

Intratumoral administration of CD1c (BDCA-1)⁺ and CD141 (BDCA-3)⁺ myeloid dendritic cells in combination with talimogene laherparepvec in immune checkpoint blockade refractory advanced melanoma patients: a phase I clinical trial.

Authors: Schwarze JK Tijtgat J Awada G et al.

Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Sep; Vol. 10 (9).

Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't

Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Print Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors.

Authors: Awada G Schwarze JK Tijtgat J et al.

Source: Melanoma research [Melanoma Res] 2022 Jun 01; Vol. 32 (3), pp. 183-191. Date of Electronic Publication: 2022 Mar 29.

Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

Journal Info: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9109623 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5636 (Electronic) Linking ISSN: 09608931 NLM ISO Abbreviation: Melanoma Res Subsets: MEDLINE